PIOLAX (5988) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
16 Mar, 2026Executive summary
Management shifted focus from automobile production to new products and regions, introducing a business unit system and organizational reforms for flexibility amid industry changes like electrification and rising costs.
Net sales for FY25 were ¥63,351 million, down 1.9% year-over-year, with operating profit declining 49.9% to ¥2,382 million and profit attributable to owners of parent dropping 55.3% to ¥1,792 million.
Financial highlights
FY24 sales: ¥63.3 billion; FY25 forecast: ¥62.0 billion; FY30 target: ¥85.0 billion.
Operating profit FY24: ¥2.3 billion; FY25 forecast: ¥2.1 billion; FY30 target: ¥9.0 billion.
Net income FY24: ¥1.8 billion; FY25 forecast: ¥1.2 billion; FY30 target: ¥6.6 billion.
Gross profit for FY2025 was ¥14,271 million, down from ¥16,263 million in FY2024.
Basic earnings per share fell to ¥52.67 from ¥117.88 year-over-year.
Outlook and guidance
FY25 guidance revised downward based on OEM trends; FY26 forecast: net sales ¥62,000 million, operating profit ¥2,100 million, profit attributable to owners of parent ¥1,200 million, and basic EPS ¥45.79.
Dividend forecast for FY2026 is ¥92.00 per share, with a payout ratio of 200.9%.
Targeting ROE of 8%+ by FY27, with focus on product development, organizational efficiency, and productivity improvements at the new Moka Plant.
Latest events from PIOLAX
- Sales up 3.2% but profits down; focus on CASE, global growth, and capital returns.5988
Q2 202516 Mar 2026 - Sales rose but profits fell on higher costs; full-year profit forecast remains lower.5988
Q1 202516 Mar 2026 - Net income fell 52% year-over-year as sales and profitability declined, with guidance unchanged.5988
Q3 202516 Mar 2026 - Profits and sales fell sharply, prompting strategic focus on innovation and cost control.5988
Q2 202616 Mar 2026 - Profits and comprehensive income fell sharply, with a cautious outlook for the full year.5988
Q1 202616 Mar 2026 - Profits and comprehensive income fell sharply, but a moderate recovery is forecasted.5988
Q3 202616 Mar 2026